Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.

Source:http://linkedlifedata.com/resource/pubmed/id/16954320

Download in:

View as

General Info

PMID
16954320